BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36224625)

  • 1. Identification of human MHC-I HPV18 E6/E7-specific CD8 + T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice.
    Peng S; Xing D; Ferrall L; Tsai YC; Hung CF; Wu TC
    J Biomed Sci; 2022 Oct; 29(1):80. PubMed ID: 36224625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions.
    Evans C; Bauer S; Grubert T; Brucker C; Baur S; Heeg K; Wagner H; Lipford GB
    Cancer Immunol Immunother; 1996 Mar; 42(3):151-60. PubMed ID: 8640843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.
    Olson BM; Frye TP; Johnson LE; Fong L; Knutson KL; Disis ML; McNeel DG
    Cancer Immunol Immunother; 2010 Jun; 59(6):943-53. PubMed ID: 20140431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ epithelial cancers.
    Riemer AB; Keskin DB; Zhang G; Handley M; Anderson KS; Brusic V; Reinhold B; Reinherz EL
    J Biol Chem; 2010 Sep; 285(38):29608-22. PubMed ID: 20615877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.
    Antal Z; Baker JC; Smith C; Jarchum I; Babad J; Mukherjee G; Yang Y; Sidney J; Sette A; Santamaria P; DiLorenzo TP
    J Immunol; 2012 Jun; 188(11):5766-75. PubMed ID: 22539795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour.
    Doan T; Herd K; Ramshaw I; Thomson S; Tindle RW
    Cancer Immunol Immunother; 2005 Feb; 54(2):157-71. PubMed ID: 15480657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice.
    Vertuani S; Triulzi C; Roos AK; Charo J; Norell H; Lemonnier F; Pisa P; Seliger B; Kiessling R
    Cancer Immunol Immunother; 2009 May; 58(5):653-64. PubMed ID: 18820911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity.
    Shah S; Cook KW; Symonds P; Weißer J; Skinner A; Al Omari A; Paston SJ; Pike I; Durrant LG; Brentville VA
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of HLA-A2 restricted epitopes of glypican-3 and induction of CTL responses in HLA-A2 transgenic mice.
    Jin X; Liu X; Zhou Z; Ding Y; Wu Y; Qiu J; Shen C
    Cancer Immunol Immunother; 2022 Jul; 71(7):1569-1582. PubMed ID: 34724090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8
    Jin X; Ding Y; Sun S; Wang X; Zhou Z; Liu X; Li M; Chen X; Shen A; Wu Y; Liu B; Zhang J; Li J; Yang Y; Qiu H; Shen C; He Y; Zhao G
    Cell Mol Immunol; 2021 Dec; 18(12):2588-2608. PubMed ID: 34728796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell-mediated, DNA-based vaccination against hepatitis C induces the multi-epitope-specific response of humanized, HLA transgenic mice.
    Mishra S; Lavelle BJ; Desrosiers J; Ardito MT; Terry F; Martin WD; De Groot AS; Gregory SH
    PLoS One; 2014; 9(8):e104606. PubMed ID: 25111185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel HLA-B7-restricted human metapneumovirus epitopes enhance viral clearance in mice and are recognized by human CD8
    Miranda-Katz M; Erickson JJ; Lan J; Ecker A; Zhang Y; Joyce S; Williams JV
    Sci Rep; 2021 Oct; 11(1):20769. PubMed ID: 34675220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector.
    Peng S; Tu H-F; Cheng M; Hu M-H; Tsai H-L; Tsai Y-C; Koenig C; Brayton C; Wang H; Chang Y-N; Arend RC; Levinson K; Roden RBS; Wu TC; Hung C-F
    mBio; 2023 Oct; 14(5):e0212123. PubMed ID: 37791765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice.
    Sadr-Momtaz S; Aftabi M; Behboudi E; Naderi M; Hashemzadeh-Omran A; Moradi A
    BMC Res Notes; 2023 Aug; 16(1):164. PubMed ID: 37550734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.
    Bakker AH; Hoppes R; Linnemann C; Toebes M; Rodenko B; Berkers CR; Hadrup SR; van Esch WJ; Heemskerk MH; Ovaa H; Schumacher TN
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3825-30. PubMed ID: 18308940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ.
    Soong RS; Song L; Trieu J; Knoff J; He L; Tsai YC; Huh W; Chang YN; Cheng WF; Roden RB; Wu TC; Trimble CL; Hung CF
    Clin Cancer Res; 2014 Nov; 20(21):5456-67. PubMed ID: 24893628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses.
    Han X; Gao Z; Cheng Y; Wu S; Chen J; Zhang W
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity in mice and rhesus monkeys vaccinated with recombinant vaccinia virus expressing bivalent E7E6 fusion proteins from human papillomavirus types 16 and 18.
    Zhao L; Liu B; Ren J; Feng J; Pang Z; Gao J; Zhang H; Tan W; Tian H; Ruan L
    Virol J; 2011 Jun; 8():302. PubMed ID: 21672263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice.
    Boesen A; Sundar K; Coico R
    Clin Diagn Lab Immunol; 2005 Oct; 12(10):1223-30. PubMed ID: 16210487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma.
    Chuntova P; Yamamichi A; Chen T; Narayanaswamy R; Ronseaux S; Hudson C; Tron AE; Hyer ML; Montoya M; Mende AL; Nejo T; Downey KM; Diebold D; Lu M; Nicolay B; Okada H
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35606087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.